INTERACTION OF CIPROFLOXACIN LOADED LIPOSOMES WITH PSEUDOMONAS-AERUGINOSA CELLS

被引:0
|
作者
NICHOLOV, R
KHOURY, AE
BRUCE, AW
DICOSMO, F
机构
[1] HOSP SICK CHILDREN,TORONTO M5G 1X8,ONTARIO,CANADA
[2] TORONTO HOSP,TORONTO GEN DIV,TORONTO M5G 2C4,ON,CANADA
[3] UNIV TORONTO,DEPT SURG,TORONTO M5S 1A1,ONTARIO,CANADA
来源
CELLS AND MATERIALS | 1993年 / 3卷 / 03期
关键词
CIPROFLOXACIN; LIPOSOMES; BACTERIA; PSEUDOMONAS-AERUGINOSA;
D O I
暂无
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
An antibiotic delivery system has been developed using ciprofloxacin (CIPRO) encapsulated within sonicated unilamellar vesicles (SUV) of different lipid compositions composed of dipalmitoylphospatidylcholine (DPPC), L-alpha-phosphatidylcholine (PC), phosphatidylethanolamine (PEA) and cholesterol (CHOL). The interaction of SUV (i.e. liposomes) with Pseudomonas aeruginosa (T12977) cells was studied and the effect of the liposome encapsulated antibiotic was tested. Encapsulation of CIPRO apparently increased the amount of antibiotic resident in the vicinity of bacteria in aqueous solution at neutral pH. Electrophoretic mobility measurements showed that P. aeruginosa cells were negatively charged. The zeta potential of P. aeruginosa was -11.4 +/- 2.9 mV in phosphate buffered saline at pH 7.0, and the corresponding surface charge density was -14.7 +/- 3.9 mC/m2. DPPC liposomes and PC liposomes had mean diameters of 103 +/- 35 nm and 80 +/- 25 nm, respectively. They were electrically neutral or had a small positive charge of +5.0 +/- 3.0 mC/m2 when prepared with PC:CHOL:PEA=5:1:1. The interaction and attachment of neutral or positively charged SUV to negatively charged bacterial cells was studied in an effort to increase the residency of the liposomes and CIPRO, in the vicinity of the bacterial cells.
引用
收藏
页码:321 / 326
页数:6
相关论文
共 50 条
  • [1] CIPROFLOXACIN FOR PSEUDOMONAS-AERUGINOSA MENINGITIS
    MILLAR, MR
    BRANSBYZACHARY, MA
    TOMPKINS, DS
    HAWKEY, PM
    GIBSON, RM
    LANCET, 1986, 1 (8493): : 1325 - 1325
  • [2] MECHANISM OF CIPROFLOXACIN RESISTANCE IN PSEUDOMONAS-AERUGINOSA
    KAATZ, GW
    SEO, SM
    JOURNAL OF INFECTIOUS DISEASES, 1988, 158 (03): : 537 - 541
  • [4] INTERACTION OF PYOCYANIN WITH PSEUDOMONAS-AERUGINOSA CELLS AND THEIR FRAGMENTS
    GUSEV, MV
    USHAKOVA, NA
    MICROBIOLOGY, 1980, 49 (05) : 558 - 561
  • [5] INVESTIGATION OF CIPROFLOXACIN PENETRATION INTO PSEUDOMONAS-AERUGINOSA BIOFILMS
    SUCI, PA
    MITTELMAN, MW
    YU, FP
    GEESEY, GG
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (09) : 2125 - 2133
  • [6] FACTORS INFLUENCING THE ACCUMULATION OF CIPROFLOXACIN IN PSEUDOMONAS-AERUGINOSA
    CELESK, RA
    ROBILLARD, NJ
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (11) : 1921 - 1926
  • [7] USE OF CIPROFLOXACIN IN THE TREATMENT OF PSEUDOMONAS-AERUGINOSA INFECTIONS
    FOLLATH, F
    BINDSCHEDLER, M
    WENK, M
    FREI, R
    STALDER, H
    REBER, H
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1986, 5 (02) : 236 - 240
  • [8] EVALUATION OF CIPROFLOXACIN IN THE TREATMENT OF PSEUDOMONAS-AERUGINOSA INFECTIONS
    GIAMARELLOU, H
    GALANAKIS, N
    DENDRINOS, C
    STEFANOU, J
    DAPHNIS, E
    DAIKOS, GK
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1986, 5 (02) : 232 - 235
  • [9] ORAL CIPROFLOXACIN TREATMENT OF PSEUDOMONAS-AERUGINOSA OSTEOMYELITIS
    DAN, M
    SIEGMANIGRA, Y
    PITLIK, S
    RAZ, R
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1990, 34 (05) : 849 - 852
  • [10] CIPROFLOXACIN TREATMENT OF PERIAPICAL PSEUDOMONAS-AERUGINOSA INFECTION
    BARNETT, F
    AXELROD, P
    TRONSTAD, L
    SLOTS, J
    GRAZIANI, A
    TALBOT, G
    ENDODONTICS & DENTAL TRAUMATOLOGY, 1988, 4 (03): : 132 - 137